Rotavirus immunity in the mouse

  • M. A. Franco
  • N. Feng
  • H. B. Greenberg
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 12)


Naturally attenuated animal rotaviruses have been tested as anti-rotavirus vaccines with moderate success. The development of improved vaccines will rely on our understanding of the immune mechanism that mediate clearance and protection from rotaviral reinfection. The mouse model of rotavirus infection is a versatile tool for studying these mechanisms: mice have a relative low cost and there is a rapidly increasing number of immunological reagents to study rotavirus immunology. This review covers recent data on the mouse model of rotavirus infection. We show that both effector arms of the immune system (CD8 + T cells and B cells) mediate anti-rotavirus effects in vivo.


Primary Infection Heterologous Virus Adult Mouse Model Heterologous Infection Homologous Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 273: 1191–1196PubMedCrossRefGoogle Scholar
  2. 2.
    Bruce MG, Campbell I, Xiong Y, Redmond M, Snodgrass DR (1994) Recognition of rotavirus antigens by mouse L3T4-positive T helper cells. J Gen Virol: 1859–1866Google Scholar
  3. 3.
    Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ, Greenberg HB (1995) Analyses of homologous rotavirus infection in the mouse model. Virology 207: 143–153PubMedCrossRefGoogle Scholar
  4. 4.
    Chen J, Trounstine M, Alt FW, Young F, Kurahara C, Loring JF, Huszar D (1993) Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. International Immunol 5: 647–656CrossRefGoogle Scholar
  5. 5.
    Dharakul T, Rott L, Greenberg H (1990) Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol 64: 4375–4382PubMedGoogle Scholar
  6. 6.
    Dunn SJ, Burns JW, Cross TL, Vo PT, Bremont M, Greenberg HB (1994) Comparisons of VP4 and VP7 of five murine rotavirus strains. Virology 203: 250–259PubMedCrossRefGoogle Scholar
  7. 7.
    Dunn SJ, Fiore L, Werner RL, Cross TL, Broome RL, Ruggeri FM, Greenberg HB (1995) Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus. Arch Virol 140: 1969–1978PubMedCrossRefGoogle Scholar
  8. 8.
    Eiden J, Lederman HM, Vonderfecht S, Yolken R (1986) T-cell-deficient mice display normal recovery from experimental rotavirus infection. J Virol 57: 706–708PubMedGoogle Scholar
  9. 9.
    Eydelloth RS, Vonderfecht SL, Sheridan JF, Enders LD, Yolken RH (1984) Kinetics of viral replication and local and systemic immune response in experimental rotavirus infection. J Virol 50: 947–950PubMedGoogle Scholar
  10. 10.
    Feng N, Burns JW, Bracy L, Greenberg H (1994) Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol 68: 7776–7773Google Scholar
  11. 11.
    Fiore L, Dunn SJ, Ridolfi B, Ruggeri FM, Mackow ER, Greenberg HB (1995) Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. J Gen Virol: 1981–1988Google Scholar
  12. 12.
    Franco MA, Greenberg HB (1995) Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 69: 7800–7806PubMedGoogle Scholar
  13. 13.
    Franco MA, Lefevre P, Willems P, Tosser G, Lintermanns P, Cohen J (1994) Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J Gen Virol 75: 589–596PubMedCrossRefGoogle Scholar
  14. 14.
    Franco MA, Prieto I, Labbe M, Poncet D, Borras CF, Cohen J (1993) An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J Gen Virol 74: 2579–2586PubMedCrossRefGoogle Scholar
  15. 15.
    Glass RI, Gentsch J, Smith JC (1994) Rotavirus vaccines: success by reassortment? Science 265: 1389–1391PubMedCrossRefGoogle Scholar
  16. 16.
    Greenberg HB, Vo PT, Jones R (1986) Cultivation and characterization of three strains of murine rotavirus. J Virol 57: 585–590PubMedGoogle Scholar
  17. 17.
    Ho M, Glass RI, Pinsky PF, Anderson L (1988) Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis 158: 1112–1116PubMedCrossRefGoogle Scholar
  18. 18.
    Institute of Medicine (1986) New vaccine development. Establishing priorities. Diseases of importance in developing countries, vol II. National Academy Press, Washington DC, pp 308–318Google Scholar
  19. 19.
    Kapikian AZ, Chanock RM (1996) Rotaviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology, vol 2. Lippincott-Raven, Philadelphia, pp 1657–1708Google Scholar
  20. 20.
    Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB (1990) Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol 64: 1698–1703PubMedGoogle Scholar
  21. 21.
    Matsui SM, Offit PA, Vo PT, Mackow ER, Benfield DA, Shaw RD, Padilla NL, Greenberg HB (1989) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol 27: 780–782PubMedGoogle Scholar
  22. 22.
    McNeal MM, Sheridan JF, Ward RL (1992) Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 191: 150–157PubMedCrossRefGoogle Scholar
  23. 23.
    Offit PA, Boyle DB, Both GW, Hill NL, Svoboda YM, Cunningham SL, Jenkins RJ, McCrae MA (1991) Outer capsid glycoprotein VP7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. Virology 184: 563–568PubMedCrossRefGoogle Scholar
  24. 24.
    Offit PA, Clark HF (1985) Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol 54: 58–64PubMedGoogle Scholar
  25. 25.
    Offit PA, Cunningham SL, Dudzik KI (1991) Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol 65: 1318–1324PubMedGoogle Scholar
  26. 26.
    Offit PA, Dudzik KI (1989) Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol 63: 3507–3512PubMedGoogle Scholar
  27. 27.
    Offit PA, Dudzik KI (1990) Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol 64: 6325–6328PubMedGoogle Scholar
  28. 28.
    Offit PA, Shaw RD, Greenberg HB (1986) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J Virol 58: 700–703PubMedGoogle Scholar
  29. 29.
    Ramig RF (1988) The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. Microb Pathog 4: 189–202PubMedCrossRefGoogle Scholar
  30. 30.
    Riepenhoff-Talty M, Dharakul T, Kowalski E, Michalak S, Ogra PL (1987) Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol 61: 3345–3348PubMedGoogle Scholar
  31. 31.
    Sereno MM, Gorziglia MI (1994) The outer capsid protein VP4 of murine rotavirus strain Eb represents a tentative new P type. Virology 199: 500–504PubMedCrossRefGoogle Scholar
  32. 32.
    Shaw RD, Merchant AA, Groene WS, Cheng EH (1993) Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year. J Clin Microbiol 31: 188–191PubMedGoogle Scholar
  33. 33.
    Ushijima H, Morikawa S, Hasegawa A, Mukoyama A, Suzuki E, Yamamoto T, Nishio O (1995) Characterization of VP4 and VP7 of murine rotavirus (YR-1) Isolated in Japan. Fifth international symposium on double stranded RNA viruses. Abstract P 08Google Scholar
  34. 34.
    Ward RL, McNeal MM, Sheridan JF (1990) Development of an adult mouse model for studies on protection against rotavirus. J Virol 64: 5070–5075PubMedGoogle Scholar
  35. 35.
    Wolf JL, Cukor G, Blacklow NR, Dambrauskas R, Trier JS (1981) Susceptibility of mice to rotavirus infection: effects of age and administration of corticosteriods. Infect Immun 33: 565–574PubMedGoogle Scholar
  36. 36.
    Woode GN, Zheng S, Melendy DR, Ramig RF (1989) Studies on rotavirus homologous and heterologous active immunity in infant mice. Viral Immunol 2: 127–132PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1996

Authors and Affiliations

  • M. A. Franco
    • 1
  • N. Feng
    • 1
  • H. B. Greenberg
    • 1
  1. 1.Department of Medicine, Microbiology and ImmunologyStanford University School of MedicineStanfordUSA

Personalised recommendations